Research Article Sangyong Jon Corresponding Author E-mail address: syjon@kaist.ac.kr Korea Advanced Institute of Science and Technology, Department of Biological Sciences, 291 Daehak-ro, Yuseong-gu, 34141 Daejeon, KOREA, REPUBLIC OF Search for more papers by this author Abstract Cancer nanovaccines that use nanomaterials as antigens and/or adjuvant‐delivering carriers can induce tumor antigen‐specific T cell immunity and have shown potential as therapeutic modalities in in vivo animal models.
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Get in touch with Byeongjun
Contact Byeongjun, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack